• [email protected]
  • Mon - Fri: 9:00 - 18:30 GMT
Search
Rss Facebook Icon TwitterCreated with Sketch. LinkedinCreated with Sketch.
bitcoin pr buzz logo
  • HOME
  • OUR SERVICES
    • BITCOIN PRESS RELEASE SERVICE
    • SUBMIT YOUR BITCOIN PRESS RELEASE
  • LATEST PRESS RELEASES
  • FREE CONSULTATION
  • OUR TEAM
  • ABOUT US
    • ABOUT
    • CAREERS
  • RESELLER
Menu
  • HOME
  • OUR SERVICES
    • BITCOIN PRESS RELEASE SERVICE
    • SUBMIT YOUR BITCOIN PRESS RELEASE
  • LATEST PRESS RELEASES
  • FREE CONSULTATION
  • OUR TEAM
  • ABOUT US
    • ABOUT
    • CAREERS
  • RESELLER

ClinTex CTi Leverages Blockchain Technology to Lower the Cost of New Medicine

  • August 22, 2018
  • Bitcoin Press Release, Ultimate Executive
Clintex Press Release

Bitcoin Press Release: CTi (Clinical Trials Intelligence) aims to bring down the cost of medicine, as well as increase the speed of access to new medicine, by reducing development costs for the global pharmaceutical industry.

August 22nd, 2018. Valletta, Malta – ClinTex, the company behind CTi, say it will achieve this by revolutionising how clinical trials are conducted through the innovative use of a combination of smart contracts both on their private consortium blockchain and on the Ethereum public blockchain. The platform is at its core a decentralised database of clinical data, but also will host 7 separate DApps, the primary function of which will be the management and optimisation of the key pain points in the conducting of clinical trials.

Clinical Trial Cost Savings = Affordable Treatments = Saved Lives

Developing new medicines is a $350 billion industry, with each new treatment requiring enormous funding and resources before it can be introduced to the market at an average of $2.5 billion per new medicine (Tufts, 2014). Nearly 80% of clinical trials are overrunning their timelines by an average of 10.8 months (Covance, 2013), which translates into as much as $8m in lost revenue each day a drug is delayed (Cutting Edge Information, 2005). Further to this, the number of clinical trials taking place is rising and along with it the associated costs, meaning the cost of new medicine is soaring.

This is the problem ClinTex intend to solve; by introducing the use of predictive analytics and machine learning to the clinical process, CTi seeks to accurately predict and prevent the costly issues and overruns that have become standard for clinical trials. If CTi delivers savings to pharma of just 1% generated applied to just 1% of global clinical trials, this means more than $35 million in savings per annum that can be passed on to patients so that they can live longer, healthier lives.

Why a Blockchain Solution for Clinical Trials?

As the FDA and other regulatory authorities need to be able to verify the quality and integrity of clinical data, the pharmaceutical company must, in accordance with Good Clinical Practice (GCP), record all changes to the data, who made the changes, and when. A blockchain ledger is the perfect record keeping tool for this use case because it does exactly that.

Further to the immutable nature of the blockchain, having a secure, complete and immutable recorded history of clinical data views stored on a blockchain will allow for the creation and evolution of a decentralised clinical database, which CTi will harness for powerful machine learning algorithms that will increase in potency over time, providing a powerful predictive tool for clinical trials that introduces hitherto untapped opportunities for efficiency and quality in the conduct of clinical research.

About ClinTex

ClinTex is a solution provider to the pharmaceutical industry. ClinTex aims to enhance clinical trial processes by providing tools to optimise operational efficiency, clinical data quality, and medical review. Furthermore, their innovative use of blockchain technology makes machine learning accessible for the end-to-end clinical trial process for the first time, allowing users to extract predictive insights from data, without needing expertise in refining machine learning models.

ClinTex CTi, a blockchain powered data management platform for the clinical trials industry, will hold a token generation event (TGE) in Q4 2018 to distribute CLX, the native token for the CTi ecosystem.

The ClinTex CTi token generation event will be one of the first to operate under the regulated environment of Malta’s Financial Services Authority (MFSA), under Malta’s Virtual Financial Assets Act, 2018.

To learn more or participate in the public sale visit their Website: https://clintex.io
Meet the Team: https://www.linkedin.com/company/eclintex-ltd/
Chat with us on Telegram: https://t.me/ClinTexCTi
Catch up on Medium: https://medium.com/clintexcti
Follow us on Twitter – https://twitter.com/ClinTexCTi

Media Contact
Contact Name: Adrian O’Donoghue
Contact Email: [email protected]

Clintex is the source of this content. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections. Cryptocurrencies and tokens are extremely volatile. There is no guarantee of a stable value, or of any value at all. Token sales are only suitable for individuals with a high-risk tolerance. Only participate in a token event with what you can afford to lose. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest.

You found our newsletter subscription!

Did you know that less than 10% of website visitors ever make it all the way to the page end?!

bitcoin pr buzz logo

Blockchain enthusiasts from the start. We have over 7 years experience in Bitcoin marketing specifically: leveraging our unique expertise, partnerships and experience we bring you the most refined, effective, and value for money Bitcoin marketing and Bitcoin press release service to be found.

Please Note:

Press releases are for informational purposes only. The information does not constitute investment advice or an endorsement by Bitcoin PR Buzz. Bitcoin PR Buzz does not certify the accuracy of the information in press releases published on this website.

Issuers of Press Releases, and not Bitcoin PR Buzz, are solely responsible for the content of press releases, and the accuracy of the content in press releases.

Quick Links

  • Press Release Services
  • Submit Press Release
  • Latest Press Release
  • Social Media Service
  • Copywriting
  • About
  • Careers
  • Terms & Conditions
  • GDPR
  • Token Sale Press Release Policy
  • INC verified
Rss Facebook-f Twitter Linkedin

Coins Accepted Here

bprb
Bitcoin News Banner

© 2021 Fintech PR LTD

Welcome to Bitcoin PR Buzz!

Your privacy is immensely important to us and we do our best to safeguard your data. We use cookies to improve your experience and to improve our services. We comply with the EU General Data Protection Regulation act also known as GDPR. We wish you a pleasant stay at bitcoinprbuzz.com, if you have any questions please feel free to chat with us below or email [email protected]

I ConsentCookie settings I need more information
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

  • →
  • Contact Us

    Contact Form

  • Telegram